Last updated on October 2018

Long Term Efficacy and Safety of Inhaled Colistimethate Sodium in Bronchiectasis Subjects With Chronic Pseudomonas Aeruginosa Infection.


Brief description of study

The co-primary objectives of the trial are to investigate the effect of the use of inhaled colistimethate sodium, administered twice daily via the I-neb for 24 months, compared to placebo in subjects with non-cystic fibrosis bronchiectasis (NCFB) chronically infected with P. aeruginosa on:

the frequency of pulmonary exacerbations; the number of exacerbation-free days.

Clinical Study Identifier: NCT03093974

Contact Investigators or Research Sites near you

Start Over

Michela Meroni, MSc

Zambon Investigative Site
Frankfurt, Germany
4.48miles
  Connect »

Michela Meroni, MSc

Zambon Investigative Site
Frankfurt am Main, Germany
8.59miles
  Connect »